Home Financial Markets Orphazyme Inc. (ORPH) stock plunged during pre-market trading. Let’s see why?

Orphazyme Inc. (ORPH) stock plunged during pre-market trading. Let’s see why?

Orphazyme Inc. (NASDAQ: ORPH) stock declined by 10.18% at last close whereas the ORPH stock price fell during the pre-market trading session by 58.18%. Orphazyme is a late-stage pharmaceutical business that is pioneering the use of heat shock proteins to treat uncommon illnesses.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What is happening?

Following its evaluation of the new drug application for arimoclomol which is a heat shock protein amplifier designed for the cure of Niemann-Pick disease type C, ORPH obtained a Final Response Letter from the US Food and Drug Administration.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

The FDA issued the CRL because it needed more qualitative and quantitative data to support the accuracy and reliability of the 5-domain NPC Clinical Severity Scale (NPCCSS), especially the swallow domain. In addition, the FDA said in the CRL that more research is required to supplement confirmatory evidence beyond the single phase 2/3 clinical trial to justify the NDA’s benefit-risk analysis.

CEO Christophe Bourdon stated,

ORPH is disappointed by the FDA’s decision, considering the critical need for a new treatment option for NPC, but they remain dedicated to working with authorities to provide arimoclomol to families dealing with this difficult condition. ORPH will concentrate their efforts on obtaining European regulatory clearance, with a CHMP opinion due in Q4 2021 and a possible Marketing Authorization in Q1 2022. In collaboration with the FDA, they are evaluating the potential route forward in the United States. To enable NPC clearance in the short term, they will need to significantly decrease their expenditures and freeze all business initiatives that are not linked to clinical and regulatory operations.

Future Expectations

Orphazyme’s original expectation for the year was subject to numerous risks and uncertainties, including but not limited to the timeliness of regulatory decisions, the effectiveness of their commercial initiatives, and the development operations, as described in ORPH’s Annual Report 2020. The result of the FDA decision will have a major impact on Orphazyme’s full-year 2021 forecast.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Orphazyme now estimates operational expenditures of DKK 700-720 million (up from DKK 800-850 million), resulting in a DKK 670-700 million operating deficit (previously DKK 100-150 million). At the end of 2021, the cash position is projected to be around DKK 50 million (previously DKK 350 million).

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

Best Inc. (BEST) stock gains during current market. Here’s the update?

Best Inc. (NASDAQ: BEST) stock rises by 5.45% during the current market. BEST Inc. is a prominent Chinese supplier of comprehensive smart supply chain...

Dolphin Entertainment Inc. (DLPN) stock rises during current market. Let’s find out why?

Dolphin Entertainment Inc. (NASDAQ: DLPN) stock gains by 17.47% to $9.21 today in the current market trading. Dolphin Entertainment is a leading independent entertainment...

General Electric Company Inc. (GE) stock sky-rocketing during pre-market. Here’s what you should know

General Electric Company Inc. (NASDAQ: GE) stock plunged by 2.56% at last close whereas the GE stock price surged massively during pre-market by 704.32%....

Related News

Immunovant Inc. (IMVT) stock plunge during current market. What’s happening?

Immunovant Inc. (NASDAQ: IMVT) stock declines by 23.42% in the current market trading. Immunovant is a clinical-stage pharmaceutical firm dedicated to helping individuals with...

Viracta Therapeutics Inc. (VIRX) stock decline during pre-market, prior to no recent update

Viracta Therapeutics Inc. (NASDAQ: VIRX) stock decline during pre-market by 2.32%. Viracta is a precision oncology firm that focuses on virus-related cancers. In two...

why Abraxas Petroleum Corporation (AXAS) stock plummeted on Friday?

Abraxas Petroleum Corporation (AXAS) shares plummeted 17.03% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $1.90 per share. However,...

ImmunoPrecise Inc. (IPA) stock fell during pre-market. What’s the update?

ImmunoPrecise Inc. (NASDAQ: IPA) stock declined by 8.39% at last close while the IPA stock-price plunge by 4.87% in pre-market as well. ImmunoPrecise is...

ECMOHO Ltd. (MOHO) stock plunged during pre-market. Let’s see what’s happening?

ECMOHO Ltd. (NASDAQ: MOHO) stock gained by 7.05% at last close, while during pre-market MOHO stock has been seen declining by 7.75%. In China's...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam